Brentuximab vedotin
Drug timelines are a Plus or Pro feature.
89 regulatory and trial events tracked for Brentuximab vedotin, covering 2011-10-26 to 2026-08-13. Get the full timeline:
Most recent: Clinical Trial Results: Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma [Phase 2]